Lanzhou Institute of Biological Products Co., Ltd
Lanzhou Institute of Biological Products Co., Ltd
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody | Infections, Mononegavirales infectious disease, RNA Virus Infections, Rhabdoviridae infectious disease, rabies, viral infectious disease | Not yet recruiting | Phase 2 | 2026-03-03 | NCT07445815 | |
| Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection | Bacterial Infections and Mycoses, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections, tetanus | Enrolling by invitation | Phase 1 | 2026-01-28 | NCT07149454 |